Molecular Cancer
Molecular Cancer is an open-access journal published by BioMed Central in the United Kingdom. OpenAlex counts 4,076 works from it, cited 456,367 times; its h-index is 302. Its two-year mean citedness, which is computed the way the impact factor is, is 38.6: a paper it published in the two years before was cited about 38.6 times last year. It published 332 papers in 2025, up 16% from 285 in 2024. Its article processing charge is about US$5,090.
- Publisher
- BioMed Central
- Citations per paper
- 38.6 two-year mean, OpenAlex
- h-index
- 302 i10-index 3,491
- Access
- Open access · in DOAJ
- APC
- US$5,090
- ISSN
- 1476-4598
- Country
- United Kingdom
- Works published
- 4,076 cited 456,367 times
- Papers in 2025
- 332
- Website
- Journal home ↗
Molecular Cancer year by year
Papers it published each year, and the citations all its papers received that year.
| Year | Papers published | Citations received |
|---|---|---|
| 2026 so far | 300 | 55,868 |
| 2025 | 332 | 62,637 |
| 2024 | 285 | 57,520 |
| 2023 | 209 | 47,594 |
| 2022 | 228 | 46,940 |
| 2021 | 173 | 42,975 |
| 2020 | 174 | 30,999 |
| 2019 | 188 | 19,125 |
What Molecular Cancer publishes
Its most frequent research topics, by OpenAlex's topic classification.
- Cancer-related molecular mechanisms researchCancer Research · 850 papers
- MicroRNA in disease regulationCancer Research · 526 papers
- Cancer Immunotherapy and BiomarkersOncology · 458 papers
- Cancer Cells and MetastasisOncology · 453 papers
- Circular RNAs in diseasesMolecular Biology · 362 papers
Questions about Molecular Cancer
What is the impact factor of Molecular Cancer?
Clarivate's Journal Impact Factor is licensed and not shown here. OpenAlex's two-year mean citedness, computed the same way from open data, is 38.6 for Molecular Cancer: on average, each paper it published in the two years before was cited about 38.6 times in a year.
What is the h-index of Molecular Cancer?
302, by OpenAlex's count: 302 of its papers have each been cited at least 302 times. Its i10-index is 3,491.
Is Molecular Cancer open access?
Yes. OpenAlex lists Molecular Cancer as an open-access journal: its papers are free to read. It is also listed in the Directory of Open Access Journals (DOAJ).
What is the publication fee (APC) of Molecular Cancer?
About US$5,090, which is its article processing charge (APC) as listed by OpenAlex. Fees change and waivers exist, so check the journal's own page before you submit.
What is the ISSN of Molecular Cancer?
Its linking ISSN is 1476-4598.
Who publishes Molecular Cancer?
BioMed Central, based in the United Kingdom.
How many papers does Molecular Cancer publish a year?
332 in 2025, by OpenAlex's count of what it published that year.
What does Molecular Cancer publish?
Its most frequent research topics are Cancer-related molecular mechanisms research, MicroRNA in disease regulation, Cancer Immunotherapy and Biomarkers, in the field of Biochemistry, Genetics and Molecular Biology.
Is Molecular Cancer a predatory journal?
Nothing in the scholarly indexes suggests so. Molecular Cancer is on OpenAlex's list of core sources, journals with peer review and an editorial board, it has published 4,076 works cited 456,367 times, and it is listed in DOAJ. For a journal you do not know, check the red flags with our predatory journal checker.
Is Molecular Cancer indexed in Scopus or Web of Science?
Check the Scopus Sources list and Clarivate's Master Journal List by its ISSN (1476-4598): both are free to search. Our guide on checking journal indexing shows each step.
Journals like Molecular Cancer
Other Biochemistry, Genetics and Molecular Biology journals with a similar impact.
Every Biochemistry, Genetics and Molecular Biology journal, ranked · The journal directory
Journal data from OpenAlex (CC0), compiled 21 November 2026. Download the whole directory as a CSV file (CC BY 4.0).